FIZZ Stock Analysis: National Beverage | NASDAQ
Beverages - Non-Alcoholic | NASDAQ, USA | Market Cap: 3.273m USD | 12M Return: 6.9% | US6350171061 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.8M
EPS Trend: 51.4%
Qual. Beats: -2
Rev. Trend: 16.8%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
National Beverage Corp. (FIZZ) is a U.S.-based beverage company that develops, produces, and markets a diversified portfolio of non-alcoholic drinks, including sparkling waters, juices, energy drinks, and carbonated soft drinks sold primarily in the United States and Canada. Its brand lineup spans LaCroix sparkling waters, Rip It energy products, Everfresh and Mr. Pure juice-based beverages, Clear Fruit waters, and legacy carbonated soft drink labels Shasta and Faygo, which it distributes through retail, convenience, food-service, and smaller up-and-down-the-street accounts. The company, founded in 1985 and headquartered in Fort Lauderdale, Florida, operates as a subsidiary of IBS Partners, Ltd.
As a mid-cap player in the Consumer Staples sector, National Beverage competes in the highly competitive soft drinks and non-alcoholic beverages sub-industry against much larger multinationals such as Coca-Cola and PepsiCo, as well as a growing field of private-label and functional beverage brands. The company is widely associated with the rapid growth of the flavored sparkling water category, where its LaCroix brand has been a key driver of consumer interest in healthier, low- and no-sugar alternatives to traditional sodas.
- LaCroix sparkling water sales decline amid intensifying competition
- Special dividends and capital returns attract income investors
- Aluminum and sugar input costs pressure beverage margins
| Net Income: 174.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.28 > 0.02 and ΔFCF/TA 4.41 > 1.0 |
| NWC/Revenue: 16.14% < 20% (prev 27.38%; Δ -11.24% < -1%) |
| CFO/TA 0.32 > 3% & CFO 187.0m > Net Income 174.9m |
| Net Debt (-48.3m) to EBITDA (241.4m): -0.20 < 3 |
| Current Ratio: 2.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (93.7m) vs 12m ago -0.04% < -2% |
| Gross Margin: 36.21% > 18% (prev 37.17%; Δ -0.96% > 0.5%) |
| Asset Turnover: 178.9% > 50% (prev 163.0%; Δ 15.91% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.33 (Total Current Assets 327.5m - Total Current Liabilities 136.9m) / Total Assets 582.3m |
| B: 0.59 (Retained Earnings 344.2m / Total Assets 582.3m) |
| C: 0.33 (EBIT TTM 217.8m / Avg Total Assets 660.0m) |
| D: 1.71 (Book Value of Equity 367.7m / Total Liabilities 214.6m) |
| Altman-Z'' = 8.09 = AAA |
| DSRI: 1.01 (Receivables 105.8m/106.5m, Revenue 1.18b/1.20b) |
| GMI: 1.03 (GM 37.17% / 36.21%) |
| AQI: 1.21 (AQ_t 0.03 / AQ_t-1 0.03) |
| SGI: 0.98 (Revenue 1.18b / 1.20b) |
| TATA: -0.02 (NI 174.9m - CFO 187.0m) / TA 582.3m) |
| Beneish M = -2.89 (Cap -4..+1) = A |
As of October 19, 2026, the stock is trading at USD 34.96 with a total of 482,385 shares traded. Over the past week, the price has changed by +14.55%, over one month by +10.42%, over three months by +12.52% and over the past year by +6.93%.
Current recommended Stop Loss: 33.70 (which is 3.6% or 1.3 ATR below the current price).
National Beverage has received a consensus analysts rating of 1.00. Therefore, it is recommended to sell FIZZ.
- StrongBuy: 0
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 31 | -11.3% |
P/E Trailing = 18.7957
P/E Forward = 18.4843
P/S = 2.7718
P/B = 7.9262
P/EG = 4.0321
Revenue TTM = 1.18b USD
EBIT TTM = 217.8m USD
EBITDA TTM = 241.4m USD
Long Term Debt = 44.3m USD (estimated: total debt 58.8m - short term 14.5m)
Short Term Debt = 14.5m USD (from shortTermDebt, last quarter)
Debt = 58.8m USD (from shortLongTermDebtTotal, last quarter) (leases 58.8m already included)
Net Debt = -48.3m USD (calculated: Debt 58.8m - CCE 107.1m)
Enterprise Value = 3.22b USD (3.27b + Debt 58.8m - CCE 107.1m)
Interest Coverage Ratio = unknown (Ebit TTM 217.8m / Interest Expense TTM 0.0)
EV/FCF = 19.92x (Enterprise Value 3.22b / FCF TTM 161.9m)
FCF Yield = 5.02% (FCF TTM 161.9m / Enterprise Value 3.22b)
FCF Margin = 13.71% (FCF TTM 161.9m / Revenue TTM 1.18b)
Net Margin = 14.81% (Net Income TTM 174.9m / Revenue TTM 1.18b)
Gross Margin = 36.21% ((Revenue TTM 1.18b - Cost of Revenue TTM 753.1m) / Revenue TTM)
Gross Margin QoQ = 35.02% (prev 34.67%)
Tobins Q-Ratio = 5.54 (Enterprise Value 3.22b / Total Assets 582.3m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 58.8m)
Taxrate = 23.70% (54.3m / 229.2m)
NOPAT = 166.2m (EBIT 217.8m * (1 - 23.70%))
Current Ratio = 2.39 (Total Current Assets 327.5m / Total Current Liabilities 136.9m)
Debt / Equity = 0.16 (Debt 58.8m / totalStockholderEquity, last quarter 367.7m)
Debt / EBITDA = -0.20 (Net Debt -48.3m / EBITDA 241.4m)
Debt / FCF = -0.30 (Net Debt -48.3m / FCF TTM 161.9m)
Total Stockholder Equity = 536.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 26.50% (Net Income 174.9m / Total Assets 582.3m)
RoE = 32.60% (Net Income TTM 174.9m / Total Stockholder Equity 536.4m)
RoCE = 37.51% (EBIT 217.8m / Capital Employed (Equity 536.4m + L.T.Debt 44.3m))
RoIC = 41.46% (NOPAT 166.2m / Invested Capital 400.8m)
WACC = 5.03% (E(3.27b)/V(3.33b) * Re(5.12%) + D(58.8m)/V(3.33b) * Rd(0.0%) * (1-Tc(0.24)))
Discount Rate = 5.12% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -25.89 | Cagr: -0.00%
[DCF] Terminal Value 74.56% ; FCFF base≈166.2m ; Y1≈158.2m ; Y5≈150.6m
[DCF] Fair Price = 25.83 (EV 2.37b - Net Debt -48.3m = Equity 2.42b / Shares 93.6m; r=8.35% [WACC [floored]]; 5y FCF grow -6.21% → 2.50% )
EPS Correlation: 51.38 | EPS CAGR: 2.57% | SUE: -4.0 | # QB: -2
Revenue Correlation: 16.77 | Revenue CAGR: 0.14% | SUE: -1.20 | # QB: -1
EPS current Quarter (2026-10-31): EPS=0.45 | Chg30d=-5.40% | Revisions=-25% | Analysts=1
EPS next Quarter (2027-01-31): EPS=0.41 | Chg30d=-3.32% | Revisions=-25% | Analysts=1
EPS current Year (2027-04-30): EPS=1.82 | Chg30d=-6.32% | Revisions=-25% | GrowthEPS=-7.0% | GrowthRev=+4.2%
EPS next Year (2028-04-30): EPS=1.96 | Chg30d=-4.78% | Revisions=-25% | GrowthEPS=+7.2% | GrowthRev=+1.4%